| 产品详情 |
| Edit |   |
|---|
| Product Name | FLT1, Recombinant, Human |
|---|
| Description | Purity ~90% (SDS-PAGE, HPLC). The flt-1 gene was first described in 1990. The receptor contains seven immunoglobulin-like extracellular domains, a single transmembrane region and an intracellular split tyrosine kinase domain. Compared to VEGFR-2 the Flt-1 receptor has a higher affinity for VEGF but a weaker signaling activity. VEGFR-1 thus leads not to proliferation of endothelial cells, but mediates signals for differentiation. Soluble FLT1 Human Recombinant produced in baculovirus is monomeric, glycosylated, polypeptide containing 688 amino acids and having a molecular mass of 96kD. The soluble receptor protein contains only the first 6 extracellular domains, which contain all the information necessary for binding of VEGF. The FLT1 is purified by proprietary chromatographic techniques. Source: Recombinant protein corresponding to 688aa from human FLT1, expressed in insect cells. Molecular Weight: ~96kD Biological Activity: Measured by its ability to bind recombinant rat VEGF-C in a f |
|---|
| Size | 10ug |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | FLT1, Recombinant, Human (Fms-like tyrosine kinase 1, Tyrosine-protein kinase FRT, Tyrosine-protein kinase receptor FLT, Vascular permeability factor receptor) |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | 169972 |
|---|
| Price | |
|---|
| Order / More Info | FLT1, Recombinant, Human from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|